HIV & AIDS

Scientists jump hurdle in HIV vaccine design

Scientists at The Scripps Research Institute (TSRI) have made another important advance in HIV vaccine design. The development was possible thanks to previous studies at TSRI showing the structures of a protein on HIV's surface, ...

Diseases, Conditions, Syndromes

Early blood signatures of vaccine immunogenicity

Within seven days of vaccination, a blood test early after vaccination can predict whether vaccines based on living, modified viruses have had the desired effect. This is one of the results of a new study from a large European ...

Diseases, Conditions, Syndromes

Scientists reveal structure of potential leishmaniasis vaccine

Leishmaniasis, caused by the bite of a sand fly carrying a Leishmania parasite, infects around a million people a year around the world. Now, making progress toward a vaccine against the parasitic disease, researchers reporting ...

Diseases, Conditions, Syndromes

Respiratory syncytial virus vaccine enters clinical testing

A Phase 1 clinical trial to test the safety and tolerability of an investigational vaccine against respiratory syncytial virus (RSV) has begun at the National Institutes of Health Clinical Center in Bethesda, Maryland. The ...

page 29 from 40